Juul Labs, Inc. was once known as PAX Labs. It was renamed Juul Labs Inc in 2017 after undergoing a metamorphosis. Juul designed compact appealing USB-like devices with pleasant flavors such as mango, cucumber, mint, and others to appeal to the youth. These electronic cigarettes are suspected for having highly addictive nicotine, resulting in a vaping pandemic among teenagers. Juul is available in two distinct nicotine levels on the market. The 5% of 0.7 millilitres has 50 milligrams, whereas the 3% contains 23 milligrams every vape pod.
Juul e-pods have been found to contain a variety of toxic chemicals that Juul does not disclose. In 2019, the term "E-Cigarette or Vaping Usage Related Lung Injury" (EVALI) was coined. Many people were taken to hospitals with lung damage caused by vaping, alerting doctors. Electronic cigarettes contain tetrahydrocannabinol (THC), which contributes to EVALI.
After North Carolina took Juul to court, a slew of other Juul lawsuits followed suit. According to a report from July 2021, Juul was facing roughly 2300 product liability lawsuits across the United States, which had been consolidated into MDL- 2913, a multidistrict litigation (MDL). The major allegation was that Juul gave away samples at events, concerts, street festivals, and movie screenings. Juul has failed to prevent minors from purchasing their goods. In the current year Juul is facing many product liability and http against Juul Labs. There are mass tort cases and wrongful death lawsuits filed against the company.
According to the most recent information, approximately 24 Juul litigation will go to trial in 2022. The first will take place on February 22nd, with the others following on March 28th, May 9th, and August 1st. Only two instances in the Juul litigation of 2021 reached a final settlement. In June 2021, North Carolina became the first state to achieve a settlement of $40 million. Arizona became the second state to negotiate a $14.5 million settlement with Juul for selling e-cigarettes to minors in November 2021.
The FDA denied marketing of flavoured e-cigarettes and vaping pods, including Juul, in September 2021, citing a lack of evidence that it would assist adult smokers stop smoking and for deceiving the younger generation into smoking.